Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: Serologic and clinical correlates

Neurology

Volumn 50, Issue 1, 1998, Pages 88-93

  O'Suilleabhain, Padraig ^a   Low, Phillip A ^a   Lennon, Vanda A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; DYSAUTONOMIA; EATON LAMBERT SYNDROME; ENZYME SPECIFICITY; FEMALE; HUMAN; MALE; MUSCLE WEAKNESS; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; SEROLOGY;

EID: 0031907458     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.88     Document Type: Article

References (24)

1. Fukuoka H, Engel, AG, Lang B, Newsom-Davis J, Prior C, Wray DW. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann Neurol 1987;22:193-199.
2. Lambert EH, Lennon VA. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities. Muscle Nerve 1988;11: 1133-1145.
3. Uchitel OD, Protti DA, Sanchez V, Cherksey BD, Sugimori M, Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 1992;89:3330-3333.
4. Sugiura Y, Woppmann A, Miljanich GP, Ko C-P. A novel ω-conopeptide for the presynaptic localization of calcium channels at the mammalian neuromuscular junction. J Neurocytol 1995;24:15-27.
5. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in Lambert-Eaton myasthenic syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
6. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-596.
7. Clark CV, Newsom-Davis J, Sanders MD. Ocular autonomic nerve function in Lambert-Eaton myasthenic syndrome. Eye 1990;4:473-481.
8. Low PA. Laboratory evaluation of autonomic failure. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. Philadelphia: Lippincott-Raven, 1997:179-208.
9. Low PA. Autonomie nervous system function. J Clin Neurophysiol 1993;10:14-27.
10. Low PA. Composite autonomie scoring scale for the laboratory quantification of generalized autonomie failure. Mayo Clin Proc 1993;68:748-752.
11. Griesmann GE, Lennon VA. Detection of autoantibodies in myasthenia gravis and Lambert-Eaton myasthenic syndrome. In: Rose NR, et al., eds. Manual of clinical and laboratory immunology. 5th ed. Washington, DC: ASM Press, 1997:983-988.
12. Lennon VA. The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1 and ANNA-2 autoantibodies [special correspondence]. Neurology 1994;44:2412-2415.
13. Dropcho EJ. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol 1996;39:659-667.
14. Lennon VA, Manley HA, Kim K-K, Parisi JE, Kilimann MW, Benarroch EE. Amphiphysin autoantibodies: a paraneoplastic serological marker of breast and lung cancer-related encephalomyeloradiculoneuritides but not classical stiffman syndrome [abstract]. Neurology 1997;48:A434.
15. McEvoy KM, Windebank AJ, Daube JR, Low PA. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567-1571.
16. Dau PC, Denys EH. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome. Ann Neurol 1982;11:570-575.
17. Khurana RK, Koski CL, Mayer RF. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. J Neurol Sci 1988;85: 77-86.
18. Oguro-Okano M, Griesmann GE, Wieben ED, Slaymaker S, Snutch TP, Lennon VA. Molecular diversity of neuronal type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 1992;67:1150-1159.
19. Lundy PM, Frew R. Effect of ω-agatoxin-IVA on autonomie neurotransmission. Eur J Pharmacol 1994;261:79-84.
20. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 1988;239:57-60.
21. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 1993;32:1075-1088.
22. Waterman SA, Lang B, Newsom-Davis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomie neurons in the mouse. Ann Neurol 1997;42:147-156.
23. Lennon VA. Calcium channel and related paraneoplastic autoantibodies. In: Peter JB, Schoenfeld Y, eds. Textbook of autoantibodies. The Netherlands: Elsevier Science Publishers, 1996:139-147.
24. Martin R, Delgado JM, Molto JM, et al. Cardiovascular reflexes in patients with malignant disease. Ital J Neurol Sci 1992;13:125-129.